Abemaciclib Clinical Trials
57 actively recruiting trials across 31 locations
▼ -4 trials since September 2026
Also known as: Abemaciclib Oral, C27H32F2N8, CDK4/6 Inhibitor Therapy., LY 2835219, LY-2835219 +8 more
Pipeline
Top Sponsors
- National Cancer Institute (NCI)6
- University of Washington3
- Memorial Sloan Kettering Cancer Center3
- Eli Lilly and Company3
- Dana-Farber Cancer Institute3
Indications
- Cancer57
- Breast Cancer31
- Hormone Receptor Positive Breast Cancer6
- Metastatic Breast Cancer5
- Endometrial Cancer5
Other7 trials
Birmingham, Alabama5 trials
Childrens Hospital of Alabama
Alabama Oncology Princeton
University of Alabama at Birmingham
University of Alabama at Birmingham Comprehensive Cancer Center
University of Alabama at Birmingham Cancer Center
Duarte, California4 trials
City of Hope - Duarte
City of Hope Comprehensive Cancer Center
City of Hope Medical Center
Los Angeles, California4 trials
UCLA / Jonsson Comprehensive Cancer Center
Ellison Clinic at Saint John's
UCLA / Jonsson Comprehensive Cancer Center
Boston, Massachusetts4 trials
Dana Farber Cancer Institute
Massachusetts General Hospital Cancer Center
Dana Farber Cancer Institute
Massachusetts General Hospital Cancer Center
Phoenix, Arizona2 trials
St. Joseph's Hospital and Medical Center
Mayo Clinic Hospital in Arizona
New Haven, Connecticut2 trials
Yale School of Medicine
Avenzo Therapeutics Recruiting Site
Tampa, Florida2 trials
Moffitt Cancer Center
Moffitt Cancer Center
Bethesda, Maryland2 trials
National Institutes of Health Clinical Center
National Institutes of Health Clinical Center
Basking Ridge, New Jersey2 trials
Memorial Sloan Kettering at Basking Ridge (All protocol activities)
Memorial Sloan Kettering Basking Ridge
Seattle, Washington2 trials
Fred Hutch/University of Washington Cancer Consortium
Fred Hutch/University of Washington Cancer Consortium
Huntsville, Alabama1 trial
Clearview Cancer Institute - Huntsville
Anchorage, Alaska1 trial
Gilbert, Arizona1 trial
Scottsdale, Arizona1 trial
Mayo Clinic Scottsdale
Fullerton, California1 trial
Providence Medical Foundation
Irvine, California1 trial
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Orange, California1 trial
Chao Family Comprehensive Cancer Center, University of California, Irvine
San Francisco, California1 trial
University of California, San Francisco
Aurora, Colorado1 trial
University of Colorado Cancer Center
Washington D.C., District of Columbia1 trial
Georgetown University Medical Center
Jacksonville, Florida1 trial
Orlando, Florida1 trial
Florida Cancer Specialists
Chicago, Illinois1 trial
University of Illinois
Baltimore, Maryland1 trial
Johns Hopkins University (Data Collection Only)
St Louis, Missouri1 trial
Siteman Cancer Center at Washington University
Lebanon, New Hampshire1 trial
Dartmouth Hitchcock Medical Center
Belleville, New Jersey1 trial
RWJBarnabas Health Clara Maas Medical Center
New York, New York1 trial
Mount Sinai Beth Israel
Philadelphia, Pennsylvania1 trial
Abramson Cancer Center of the University of Pennsylvania
Dallas, Texas1 trial
Parkland Hospital
Houston, Texas1 trial
UT MD Anderson Cancer Center
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.